News for Aastrom Biosciences Inc - Google Finance

Aastrom Biosciences Inc (NASDAQ:ASTM) up by 4.53%, Hansen Medical Inc ...

Tue, 28 May 2013 18:24:40 GMT

Aastrom Biosciences Inc (NASDAQ:ASTM) up by 4.53%, Hansen Medical Inc ...
NIS - May 28, 2013

New York, NY - (NISMAGAZINE) - 5/28/2013- Aastrom Biosciences Inc (NASDAQ:ASTM) Tuesday's trading session saw Aastrom Biosciences Inc (NASDAQ:ASTM) up by 4.53%. It opened at a price of $0.58 which reached an intraday high of $0.59 before ...

Standard Operating Procedure – offerings enhance future rewards but offset ...

Tue, 18 Jun 2013 20:04:45 GMT

Standard Operating Procedure – offerings enhance future rewards but offset ...
Proactive Investors USA & Canada - 14 hours ago

Still awaiting the Aastrom (ASTM) $25 M offering … it must be imminent as the shares have been gyrating - but, what has taken so long?

Stocks extend losses amongst fading sentiment

Fri, 14 Jun 2013 18:30:19 GMT

Stocks extend losses amongst fading sentiment
Proactive Investors USA & Canada - Jun 14, 2013

Harvard Biosciences (HBIO) is DOWN… -$0.01 at $4.95 on decreasing trading volumes and overall market conditions, with a trading range of ... Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a ...

Have the “go bag” ready – killer days are here

Wed, 12 Jun 2013 19:38:35 GMT

Have the “go bag” ready – killer days are here
Proactive Investors USA & Canada - Jun 12, 2013

Harvard Biosciences (HBIO) is UP… +$0.04 at $5.05 ... Nordhoff is the former CEO and Chairman of Gen-Probe, Inc., a leading molecular diagnostics company which was acquired in 2012 in an all-cash transaction that valued the company at $3.72 billion.

Aastrom Biosciences Inc Names Dominick C. Colangelo President And CEO

Wed, 06 Mar 2013 21:15:00 GMT

Aastrom Biosciences Inc Names Dominick C. Colangelo President And CEO
Reuters Key Development - Mar 6, 2013

Aastrom Biosciences Inc Announces Management Change-Form 8-K

Thu, 13 Dec 2012 03:04:00 GMT

Aastrom Biosciences Inc Announces Management Change-Form 8-K
Reuters Key Development - Dec 13, 2012

Aastrom Biosciences Inc Announces CEO Tim M. Mayleben Plan To Retire

Thu, 04 Oct 2012 20:01:00 GMT

Aastrom Biosciences Inc Announces CEO Tim M. Mayleben Plan To Retire
Reuters Key Development - Oct 4, 2012

Aastrom Biosciences, Inc. Announces Common Stock Exchange For December 2010 Warrants

Wed, 27 Jun 2012 20:05:00 GMT

Aastrom Biosciences, Inc. Announces Common Stock Exchange For December 2010 Warrants
Reuters Key Development - Jun 27, 2012

Aastrom Biosciences, Inc.'s Ixmyelocel-T Protect Heart From Damage In Murine Model Of Heart Failure

Wed, 06 Jun 2012 22:00:00 GMT

Aastrom Biosciences, Inc.'s Ixmyelocel-T Protect Heart From Damage In Murine Model Of Heart Failure
Reuters Key Development - Jun 6, 2012

Aastrom Biosciences, Inc. Announces Final Results From RESTORE-CLI Phase 2b Clinical Trial For Ixmyelocel-T

Thu, 05 Apr 2012 13:00:00 GMT

Aastrom Biosciences, Inc. Announces Final Results From RESTORE-CLI Phase 2b Clinical Trial For Ixmyelocel-T
Reuters Key Development - Apr 5, 2012